Skip to content
Unclaimed
Discovery tool, not advice. Every figure is the published rule, not a decision on your case.
Equity

Boehringer Ingelheim Venture Fund

Status

Open continuously

No deadline — apply whenever you are ready.

Always open
Amount
Not published

Corporate venture fund investing in early-stage biomedical companies. Initial tickets are commonly in the low single-digit millions of euro with reserves for follow-on rounds.

Funder

Boehringer Ingelheim Venture Fund GmbH

private · national

Deadline: Open all year — Opportunities reviewed on a rolling basis; no fixed call.

Your odds
Not published

This funder does not publish a success rate. We rank it using the rate observed across similar programmes and label it as an estimate rather than implying we know.

Effort
quick

Quick — mostly identity and bank details.

Who can apply

Focus on immuno-oncology, regenerative medicine, infectious disease, digital therapeutics and biotherapeutics; invests in Europe, North America and Israel.

Apply on the funder's site

Source. https://www.boehringer-ingelheim.com/science/partnering/venture-fund · not human-checked

Verified on 14 August 2026

Source: www.boehringer-ingelheim.com

Similar programmes

Paid, separate from Unclaimed

Want a human to review your application?

Involve Consulting can help — a paid expert-review service run by the same person behind Unclaimed, entirely separate from this free check. A flat fee, agreed up front; never a cut of what you receive.

Talk to Involve Consulting